EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

9.18 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Operating Activities:
Net Income -70.795-102.254-58.417-45.394-56.793-53.171-18.485-21.5476.347-13.355-11.9-24.835-8.6288.753-2.511-75.67-103.675-20.913-11.486-5.225-3.598
Depreciation & Amortization 0.4642.4462.7712.6492.6041.1480.8150.9080.8820.9170.9942.2273.3553.3263.4380.3978.7188.6991.2420.2410.212
Deferred Income Tax 0.0830-0.7870.9053.8126.278000-0.0780-0.013-0.2090.001-0.094-0.535-23.529-7.068000
Stock Based Compensation 12.05714.1777.4475.5474.5683.9672.7042.4562.1631.9611.4111.3171.4112.0521.495000000
Change In Working Capital 58.882-3.023-1.73920.136-12.5360.9250.3182.0731.0090.3890.692-2.7151.211-4.015-10.45213.4550.1472.189-0.3390.5640.259
Accounts Receivables 14.432-2.662-10.6034.846-15.3040.0070.2190.116-0.1240.1030.364-0.1280.285-0.29-0.29000000
Inventory -1.553-0.761.347-3.2-1.859-0.7590.5511.2230.9170.7290.016-0.7560.11-0.3080000000
Accounts Payables 1.5191.1988.4761.8724.5961.747-0.3460.6260.292-0.2130.2770.064-0.0640.11-2.156000000
Other Working Capital 44.484-0.799-0.95916.6180.031-0.07-0.1060.108-0.076-0.230.035-1.8950.88-3.527-8.296000000
Other Non Cash Items 1.18423.6490.6281.7221.6480.209-5.5940.0870.0980.0450.15214.924-0.9510.3390.31157.22392.2871.451.24-1.0160.067
Operating Cash Flow 1.875-65.005-50.097-14.435-56.699-21.907-20.49-16.31610.297-10.671-8.745-9.001-3.179.899-8.436-5.143-21.215-16.139-9.344-5.435-3.06
Investing Activities:
Investments In Property Plant And Equipment -3.483-2.15-0.156-0.362-0.213-0.108-0.147-0.113-0.161-0.248-0.068-0.405-0.133-0.015-0.195-0.272-0.082-1.154-2.59-0.366-0.036
Acquisitions Net -0.168-0.558000-16.78-16.780.03300.0780000001.855-2.995-4,033.0580-0.418
Purchases Of Investments -55.116-139.115-32.965000-5.052-17.517-10.222-2.964-7.758-15.392-15.963-2.054-2.054000000
Sales Maturities Of Investments 55.284124000018.74313.1683.653.3514.18416.4036.5986.5980000000
Other Investing Activites 0.1680.558-32.9650000.03313.724-4.349-0.150.3146.4261.011000.01300.019-3.52700.419
Investing Cash Flow -3.315-17.265-33.121-0.362-0.213-16.88813.577-4.462-6.7330.0666.3580.606-9.498-2.069-0.195-0.2591.773-4.13-6.117-0.366-0.035
Financing Activities:
Debt Repayment -40.511-8.372-0.146-13.843-20-20000000000000000
Common Stock Issued 229.5510.395216.82549.91822.62741.5158.40416.516.9918.0574.669010.04310.043020.62227.4818.872.78425.3680.605
Common Stock Repurchased -0.169-0.295-0.15-0.09-0.12-0.195000000000000000
Dividends Paid 000000000000000000000
Other Financing Activities -1.977.9770.2231.41731.23719.1560.0990.490.2350.98719.0440.1140.0170.8020.802-2.237-17.35312.783-0.0210.311-0.032
Financing Cash Flow 187.07-0.69216.90237.49233.86460.6718.50316.990.23519.0444.6690.11410.060.8020.80218.38510.12821.6532.76425.6790.573
Other Information:
Effect Of Forex Changes On Cash 00000.0010.002-0.005-0.02-0.012-0.004-0.008-0.0060.006-0.017-0.079-0.044-1.1170.513-1.321.088-0.079
Net Change In Cash 185.63-82.96133.68422.695-23.04721.8781.585-3.8083.7878.4352.274-8.287-2.6028.615-8.7112.939-10.4311.897-14.01720.965-2.601
Cash At End Of Period 281.26395.783178.74345.05922.36438.92616.89815.31319.12115.3346.8994.62512.91215.5146.89915.6092.66811.4699.7921.7860.793